Laboratory operator Quest Diagnostics beat Wall Street estimates for fourth-quarter profit and revenue on Thursday, helped by a robust appetite for its diagnostic tests.

The "Bladder Cancer Diagnostics Market by Test Type, by Stages, by Cancer Type, by End User, and By Region" report has been ...

Quest Diagnostics' fourth-quarter net income and revenue rose beyond Wall Street expectations, and the medical firm forecast more growth in 2025 amid rising demand for its health-care tests.

Introduction An organ transplant is a surgical procedure replacing a damaged organ with a healthy one. Diagnostics for organ transplants are cl ...

The union health ministry on 6 January reported 2 cases of HMPV in Karnataka detected by ICMR during routine surveillance.

University Hospitals completes sale of about 50 outpatient lab services locations in Ohio to New Jersey-based Quest.

The Cube CYP2C19 test can be used to aid clinicians in determining therapeutic strategy for drugs metabolized by the CYP450 2C19 genetic pathway. Genomadix CubeTM CYP2C19 System identifies the CYP2C19 ...

First patients with memory problems join ‘revolutionary’ trial by Oxford and Cambridge universities which could lead to ‘Holy ...

A NEW method for detecting bowel cancer is more than 90 per cent accurate at predicting which higher risk people will develop ...

Quest Diagnostics has completed its previously announced acquisition of certain assets of University Hospital’s outpatient ...

A SIMPLE blood test that could catch dementia before major symptoms start has begun trials in NHS clinics. More than 3,000 ...

NHS are conducting a trial on citizens on blood test to diagnose dementia early, paving the way for future of dementia ...